Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2. (2021)
Attributed to:
A Programme for ALS Care in Europe (ALS-CarE)
funded by
ESRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/braincomms/fcab141
PubMed Identifier: 34409288
Publication URI: http://europepmc.org/abstract/MED/34409288
Type: Journal Article/Review
Volume: 3
Parent Publication: Brain communications
Issue: 3
ISSN: 2632-1297